Health for All

Around two billion people across the globe still do not have adequate access to health. That’s why we have made it a high priority to address the global health challenge.

Our Promise

Committed to contribute to global health, at our company, we are dedicated to human progress, and serving patients, scientists, and customers around the globe.

Our scope is to address challenges that affect millions of people, improving the health of underserved populations in low- and middle-income countries through our scientific and technological innovations and products, and the close collaborations with our partners. Our ambition is to serve with more than 170 million patients per year in low- and middle-income countries by 2030.

To do that, we drive innovative solutions, partnerships and sustainable business models to address unmet needs across the health value chain, helping to contribute to the United Nations’ 2030 Sustainable Development Goals and supporting our Sustainability Strategy. We aim to create impact for society and sustainable business value for our company.

Our Priorities

Our strategic priorities are to: expand access to our healthcare portfolio of products in low- and middle-income countries; catalyze innovative solutions to address global health challenges, including malaria; eliminate schistosomiasis as a public health problem.

We implement our strategy through transformative and sustainable products and technologies, and initiatives to improve healthcare systems. We leverage our core competencies and deliver high-quality, sustainable health solutions to create long-term value.

Our Approach

Our Global Health strategic priorities to fight infectious diseases, schistosomiasis, and malaria, translate into a comprehensive approach that integrates a portfolio of projects for existing treatments, innovative drugs, diagnostics, and preventive measures, as well as initiatives to build capacity in endemic countries. It also covers the entire value chain from research and development throughout registration, to manufacturing and supply, and health systems and access.

Our mission to provide access to health globally

Many people in low- to middle-income countries lack access to high-quality health solutions. We leverage our expertise and collaborate with strong partners to develop solutions for patients in developing healthcare systems.

To systematically address the many complex factors of access, our engagement to expand access to our health innovations and products translates into a holistic framework organized along three pillars:

Availability

Driving the development of solutions to address health challenges, using needs-based Research & Development and responsible Intellectual Property while planning for fastest and broadest access to innovation.
Accessibility

Strengthening health services and infrastructure in low- and middle-income countries to enable patient access to the best possible care.
Affordability

Implementing innovative mechanisms for equitable and sustainable access to our innovations and products.

Our position in the Top Five of the Access to Medicine Index 2022 demonstrates our firm commitment to Health for All. Our healthcare products for non-communicable diseases reach over 50 Mio patients per year in low-and middle-income countries; in partnership with the World Health Organization, since 2007, we have provided over 1.7 billion tablets of praziquantel and treated 80 Mio patients in 2022, mainly school-aged children, with schistosomiasis.

Access to Healthcare

We enable sustainable access to our solutions to address local needs through collaborative partnerships and a holistic approach to health.
Learn more
Access for NTDs

Setting up a new access path, complementary to donations, to extend population reach and move towards long-term sustainability.

Learn More

More than a decade ago we committed ourselves to the fight against schistosomiasis. Learn more about our efforts to eliminate the disease.

Malaria is a major health and social issue. As One Against Malaria we focus on products and technologies to prevent, control and potentially eradicate malaria.

Gender equality requires urgent actions to address the many challenges in health for women in low- and middle-income countries.

The Healthy Women, Healthy Economies initiative strives to unleash the economic power of women by bringing governments, employers and other interested stakeholders together to help to improve women’s health so women - and by extension their families - can join, thrive, rise in their communities and live better lives.

Inclusive and sustainable development requires that urgent actions are taken to ensure health and well-being for all children. Our global health programs aim to address current challenges through health innovations for the most vulnerable population.

Our Contact

The team can be contacted at: GlobalHealth@emdgroup.com